Ifp Advisors, Inc Global Blood Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$25.48 - $37.34 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$32.46 - $43.42 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$38.94 - $50.85 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	SELL	$37.65 - $63.77 $1,882 - $3,188	-50 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$52.76 - $74.49 $2,638 - $3,724	50 New	50 $3,000
Q2 2020 Aug 05, 2020	BUY	$48.73 - $81.82 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$41.72 - $87.2 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	BUY	$45.7 - $81.86 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	BUY	$45.35 - $57.91 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	SELL	$39.99 - $53.48 $21,994 - $29,414	-550 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$38.0 - $51.1 $20,900 - $28,105	550 New	550 $0

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.